22 Oct 2018 maja Uncategorized Evaluating the risk of developing acute myeloid leukemia or myelodysplastic syndrome after a stem cell transplant Evaluating the risk of developing acute myeloid leukemia or myelodysplastic syndrome after a stem cell transplant This study evaluated the risk Read More
22 Oct 2018 maja Uncategorized Hodgkin Lymphoma Above and Below the Diaphragm: Are The Outcomes Different? Hodgkin Lymphoma Above and Below the Diaphragm: Are The Outcomes Different? This study investigated the development of Hodgkin lymphoma (HL) Read More
22 Oct 2018 maja Hronična limfocitna leukemija Chlorambucil, rituximab and lenalidomide combination treatment for patients with chronic lymphocytic leukemia Chlorambucil, rituximab and lenalidomide combination treatment for patients with chronic lymphocytic leukemia This study aimed to evaluate the Read More
22 Oct 2018 maja Hronična limfocitna leukemija Evaluating the safety of ibrutinib in leukemia and lymphoma Evaluating the safety of ibrutinib in leukemia and lymphoma This study looked at the evidence for the safety of ibrutinib (Imbruvica) in the Read More
13 Apr 2018 maja Nehočkinski limfom Diffuse large B-cell lymphoma: 10 years’ real-world clinical experience with rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisolone Diffuse large B-cell lymphoma: 10 years’ real-world clinical experience with rituximab plus cyclophosphamide, doxorubicin, vincristine and Read More